Has van Ha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $58 in general payments to van Ha, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean van Ha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about van Ha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

van Ha, MD

Dermatology · Leesburg, VANPI 1649263195

Payments from drug & device makers

$58in general payments, 2019–2025

Across 4 payments — averaging $14.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$29
Pfizer$15
Ortho Dermatologics, A Division Of Bausch Health US, LLC$13

What the payments were for

Food & beverage$2951%
Education$2949%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	2	$29
Pfizer	1	$15
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$13

How this compares

$58 in reported general payments places this provider in the 5th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia →

Medicare billing

Part B allowed, 2024

$728,076

Medicare patients

1,468

Services billed

10,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TremfyaGuselkumab	24	$326,206
Skyrizi PenRisankizumab-Rzaa	13	$260,958
Dupixent PenDupilumab	54	$189,747
Cosentyx Sensoready (2 Pens)Secukinumab	16	$177,634
OtezlaApremilast	24	$114,931
Doxycycline Ir-DrDoxycycline Monohydrate	20	$27,059
Minoxidil	462	$3,802
Clobetasol Propionate	50	$2,826
Fluorouracil	45	$2,649
Tacrolimus	12	$2,204
Mupirocin	280	$1,963
Halobetasol Propionate	29	$1,609
Cefadroxil	199	$1,532
Mometasone Furoate	62	$1,472
Desonide	45	$903

Paid to pharmacies, not to this prescriber.

Other dermatology in Leesburg

Vishal PatelLeesburg$1.1M
David PariserNorfolk$7M
Jennifer DesimoneFairfax$2.3M
Naiem IssaVienna$2M
Saurabh SinghFairfax$1.7M
Diego DasilvaVirginia Beach$1.1M
Carrie CobbLynchburg$859K
Yvonne KnightRichmond$857K
David BrayAlexandria$799K
Cyndi Torosky TommasoVirginia Beach$717K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →